Clinical Trial Update: To Determine Long Term Efficacy and Safety of Asenapine in Schizophrenic Patient Population (A7501012)(COMPLETED)(P05770) [Phase 3]

View source ↗

Summary

A Phase 3 trial update assessing long-term efficacy and safety of asenapine in schizophrenia has been completed with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Asenapine (asenapine)

Snippet

Sponsor: Organon and Co | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2010-05-28